Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing the pectolinarigenin production in <i>Clerodendrum phlomidis</i> L. f. cell suspension cultures and machine learning-based predictive modeling.

Frontiers in plant science·2026
Same author

Mpox Vaccine Hesitancy Among Sexually Active People with HIV in Care at Risk for mpox.

AIDS and behavior·2026
Same author

Repeat Behavioral Counseling, With and Without Combination Nicotine Replacement Therapy, for Smoking Cessation Among People With HIV in South Africa.

AIDS and behavior·2026
Same author

Diagnosis and management of allergic rhinitis: An Indian expert consensus by otorhinolaryngologists.

Asia Pacific allergy·2025
Same author

Markov Modeling to Estimate the Population Impact of Emerging Tobacco Products: A Proof-of-Concept Study.

Tobacco regulatory science·2025
Same author

Differences in Methamphetamine Use, Self-Reported Impact, and HIV-Related Outcomes by Gender and Sexual Orientation in a Multisite U.S. Cohort of People with HIV in Care.

AIDS and behavior·2025

Related Experiment Video

Updated: Jun 20, 2026

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
10:47

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

HIV & smoking in India.

S Ramesh Kumar1, Soumya Swaminathan, Timothy Flanigan

  • 1Tuberculosis Research Centre (ICMR), Chennai, India.

The Indian Journal of Medical Research
|August 25, 2009
PubMed
Summary
This summary is machine-generated.

Smoking significantly increases health risks for people living with HIV/AIDS (PLWHA) in India, including higher rates of infections like TB and poorer treatment responses. Effective smoking cessation interventions are crucial for this vulnerable population.

More Related Videos

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

Related Experiment Videos

Last Updated: Jun 20, 2026

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
10:47

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

Area of Science:

  • Public Health
  • Infectious Diseases
  • HIV/AIDS Research

Background:

  • India has 2.5 million people living with HIV/AIDS (PLWHA), with young individuals being particularly vulnerable.
  • Smoking prevalence is rising in India, especially among rural, lower socio-economic, and illiterate men.
  • HIV-infected smokers face increased risks of infectious and non-infectious complications, including malignancies, cardiovascular events, and poorer antiretroviral therapy response.

Purpose of the Study:

  • To review the critical importance of smoking cessation interventions for people living with HIV/AIDS (PLWHA) in India.
  • To highlight the compounded risks faced by HIV-infected smokers, including increased susceptibility to tuberculosis (TB) and higher mortality rates.
  • To emphasize the need for tailored and comprehensive smoking cessation strategies within primary care for HIV-infected individuals.

Main Methods:

  • This is a review article, synthesizing existing research on smoking cessation and HIV/AIDS in the Indian context.
  • It examines the impact of smoking on immunological mechanisms and host defenses in HIV-infected individuals.
  • It discusses the challenges and complexities of implementing smoking cessation interventions in this population, considering co-existing psychosocial issues.

Main Results:

  • HIV-infected smokers exhibit suppressed immune defenses and a higher risk of developing TB, leading to increased morbidity and mortality.
  • Standard smoking cessation methods (nicotine replacement therapy, bupropion, varenicline) show variable success and may be complicated by psychosocial factors.
  • There is a significant need for more clinical trials to establish effective smoking cessation interventions specifically for HIV-infected persons in India.

Conclusions:

  • Smoking cessation is paramount for improving health outcomes and reducing mortality among people living with HIV/AIDS (PLWHA) in India.
  • Integrated smoking cessation counseling into primary care for HIV management is essential.
  • Public health measures, including policy changes and comprehensive guidelines for healthcare workers, are vital to address this public health challenge.